← FDA Drug Approvals (Drugs@FDA)

COLUMVI

BLA · Biologics License Application · Sponsor: GENENTECH INC · Approved 2023-06-15

Drug application

FDA Application #

BLA761309

Application type

Biologics License Application

Brand name

COLUMVI

Generic name

GLOFITAMAB

Active ingredients

GLOFITAMAB-GXBM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

GENENTECH INC

Manufacturer

Genentech, Inc.

First approval

2023-06-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown